Advertisement
New Zealand markets close in 7 hours
  • NZX 50

    11,836.04
    -39.31 (-0.33%)
     
  • NZD/USD

    0.5904
    -0.0015 (-0.26%)
     
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • OIL

    82.51
    -0.22 (-0.27%)
     
  • GOLD

    2,394.40
    -3.60 (-0.15%)
     

Microchip Technology (MCHP) Just Reclaimed the 20-Day Moving Average

From a technical perspective, Microchip Technology (MCHP) is looking like an interesting pick, as it just reached a key level of support. MCHP recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving averages.

The 20-day moving average can show signals that are similar to other SMAs as well. If a stock's price is moving above the 20-day, the trend is considered positive. When the price falls below the moving average, it can signal a downward trend.

Moving Average Chart for MCHP
Moving Average Chart for MCHP

Over the past four weeks, MCHP has gained 9.8%. The company is currently ranked a Zacks Rank #3 (Hold), another strong indication the stock could move even higher.

ADVERTISEMENT

Looking at MCHP's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 10 revisions higher for the current fiscal year compared to none lower, and the consensus estimate has moved up as well.

Investors should think about putting MCHP on their watchlist given the ultra-important technical indicator and positive move in earnings estimate revisions.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microchip Technology Incorporated (MCHP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research